MTMR2 and congenital muscular dystrophy: Abnormalities of phosphoinositide metabolism have not yet been described in CMD but have been observed in several other neuromuscular conditions including non-dystrophic myotubular myopathy caused by mutations in MTM1, encoding the phosphoinositide 3-phosphatase myotubularin.17